ASLAN Pharmaceuticals

Filed a patent for "treatment of atopic dermatitis employing anti-il-13ra1 antibody or binding fragment thereof in an allergic population" on Thu, March 23, 2023

Filed a patent for "treatment of atopic dermatitis employing anti-il-13ra1 antibody or binding fragment thereof" on Thu, January 5, 2023

Filed a patent for "treatment and/or prevention of a viral infection" on Thu, November 9, 2023

Filed a patent for "treatment of autoimmune skin disease" on Thu, October 26, 2023

Filed a patent for "pyridopyrimidine derivatives useful in modulation of ahr signalling" on Thu, September 7, 2023